University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)

为了促进主要性传播疾病疫苗的开发，NIAID宣布， U19性传播感染合作研究中心（STI CRC）。在答复时 北卡罗来纳州大学衣原体疫苗倡议组织（UNC-CVI）召集了一组经验丰富的 衣原体研究人员、性传播感染临床医生和疫苗开发专家， 疫苗，以防止衣原体感染对健康和生殖造成的破坏性后果， 妇女UNC-CVI将是一个大型和多方面的组织，包括核心、项目和 在多个国家和国际网站的合作者。建立和维护基础设施， 行政核心的职责是确保企业的平稳高效运行 A.由中心PI托尼达维尔医学博士和项目PI凯瑟琳奥康奈尔博士领导，并得到以下资源的支持： 查佩尔山，全国领先的研究型大学之一。核心A领导层将联合收割机 具有行政管理经验的专业知识，以确保圆满完成以下具体目标：1 - 行政监督，确保UNC-CVI科学家和工作人员协同工作， 该中心的研究计划的短期和长期目标，包括财务管理，资源 2.通信监督-为通信系统的不同组成部分提供一个渠道， 中心和NIH共享数据和结果，排除障碍，并向 科学界和公众; 3 -科学监督-监测里程碑和可交付成果，以及 监督冲突解决、试剂和数据共享以及知识产权问题; 监督，开发和管理发展研究计划，以支持研究和 下一代STI疫苗研究人员的职业生涯; 5 -生物统计支持小组，确保中心 项目和DRP获奖者可以获得有效的基本， 转化和临床研究。

To advance the development of vaccines against major sexually-transmitted diseases, NIAID announced the the U19 Sexually Transmitted Infections Cooperative Research Center (STI CRC) program. In response, the University of North Carolina Chlamydia Vaccine Initiative (UNC-CVI) has assembled a group of seasoned Chlamydia researchers, STI clinicians and vaccine development experts to address the development of a vaccine to prevent the often-devastating health and reproductive consequences of Chlamydia infection in women. UNC-CVI will be a large and multifaceted organization, encompassing cores, projects and collaborators at multiple national and international sites. Establishing and maintaining the infrastructure to ensure the smooth and efficient running of this enterprise will be the responsibility of the Administrative Core A. Headed by Center PI Toni Darville MD and project PI Catherine O’Connell PhD, and backed by resources at UNC Chapel Hill, one of the country’s leading research universities. Core A leadership will combine scientific expertise with administrative experience to ensure the successful completion of the following specific aims: 1 – Administrative oversight, ensure that UNC-CVI scientists and staff work synergistically to accomplish the short- and long-term goals of the Center’s research program, including management of finances, resources and biospecimens; 2 – Communications oversight – provide a conduit for the disparate components of the Center and NIH to share data and results, troubleshoot roadblocks, and disseminate information to the scientific community and the public; 3 – Scientific oversight – monitoring milestones and deliverables, and overseeing conflict resolution, reagent- and data sharing and intellectual property issues; 4 – Developmental oversight, developing and administering the Development Research Program, to support the research and careers of the next generation of STI vaccine researchers; 5 – Biostatistical support group, ensuring the Center projects and DRP awardees have access to the cutting-edge statistical expertise essential for effective basic, translational and clinical research.